7-144095886-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004135.2(OR2A12):c.779C>T(p.Ala260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,613,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004135.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2A12 | NM_001004135.2 | c.779C>T | p.Ala260Val | missense_variant | 2/2 | ENST00000641592.1 | NP_001004135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2A12 | ENST00000641592.1 | c.779C>T | p.Ala260Val | missense_variant | 2/2 | NM_001004135.2 | ENSP00000493157.1 | |||
OR2A12 | ENST00000408949.2 | c.779C>T | p.Ala260Val | missense_variant | 1/1 | 6 | ENSP00000386174.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249310Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135250
GnomAD4 exome AF: 0.0000588 AC: 86AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.0000701 AC XY: 51AN XY: 727242
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74280
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.779C>T (p.A260V) alteration is located in exon 1 (coding exon 1) of the OR2A12 gene. This alteration results from a C to T substitution at nucleotide position 779, causing the alanine (A) at amino acid position 260 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at